[1] |
Li Y, Xu QQ, Shan CS, et al. Combined use of emodin and ginsenoside Rb1 exerts synergistic neuroprotection in cerebral ischemia/reperfusion rats[J]. Front Pharmacol, 2018, 9: 943.
|
[2] |
Nogueira RG, Jadhav AP, Haussen DC, et al. Thrombectomy 6 to 24 hours after stroke with a mismatch between deficit and infarct[J]. N Engl J Med, 2018, 378(1): 11-21.
|
[3] |
Zhang ZG, Chopp M. Promoting brain remodeling to aid in stroke recovery[J]. Trends Mol Med, 2015, 21(9): 543-548.
|
[4] |
Yang J, Zhang X, Chen X, et al. Exosome mediated delivery of miR-124 promotes neurogenesis after ischemia[J]. Molecular Therapy-Nucleic Acids, 2017, 7: 278-287.
|
[5] |
Gage MC, Thippeswamy T. Inhibitors of Src family kinases, inducible nitric oxide synthase, and NADPH oxidase as potential CNS drug targets for neurological diseases[J]. CNS Drugs, 2021, 35(1): 1-20.
|
[6] |
Jo M, Lee J, Kim HG, et al. Anti-inflammatory effect of barringtonia angusta methanol extract is mediated by targeting of Src in the NF-kappaB signalling pathway[J]. Pharm Biol, 2021, 59(1): 799-810.
|
[7] |
Yang M, Xu W, Wang Y, et al. CD11b-activated Src signal attenuates neuroinflammatory pain by orchestrating inflammatory and anti-inflammatory cytokines in microglia[J]. Mol Pain, 2018, 14: 1744806918808150.
|
[8] |
Yang H, Wang L, Zang C, et al. Src inhibition attenuates neuroinflammation and protects dopaminergic neurons in parkinson's disease models[J]. Front Neurosci, 2020, 14: 45.
|
[9] |
Zhang Y, Zeng X, Wang H, et al. Dasatinib self-assembled nanoparticles decorated with hyaluronic acid for targeted treatment of tumors to overcome multidrug resistance[J]. Drug Deliv, 2021, 28(1): 670-679.
|
[10] |
Cruz FF, Horta LF, Maia LA, et al. Dasatinib reduces lung inflammation and fibrosis in acute experimental silicosis[J]. PLoS One, 2016, 11(1): e0147005.
|
[11] |
Da SAL, Magalhaes RF, Branco VC, et al. The tyrosine kinase inhibitor dasatinib reduces lung inflammation and remodelling in experimental allergic asthma[J]. Br J Pharmacol, 2016, 173(7): 1236-1247.
|
[12] |
Dhawan G, Combs CK. Inhibition of Src kinase activity attenuates amyloid associated microgliosis in a murine model of Alzheimer's disease[J]. J Neuroinflammation, 2012, 9: 117.
|
[13] |
Ryu KY, Lee HJ, Woo H, et al. Dasatinib regulates LPS-induced microglial and astrocytic neuroinflammatory responses by inhibiting AKT/STAT3 signaling[J]. J Neuroinflammation, 2019, 16(1): 190.
|
[14] |
Liang S, Pong K, Gonzales C, et al. Neuroprotective profile of novel SRC kinase inhibitors in rodent models of cerebral ischemia[J]. J Pharmacol Exp Ther, 2009, 331(3): 827-835.
|
[15] |
Wu H, Peng B, Mohammed FS, et al. Brain targeting, antioxidant polymeric nanoparticles for stroke drug delivery and therapy[J]. Small, 2022: e2107126.
|
[16] |
Li C, Zhao Z, Luo Y, et al. Macrophage-disguised manganese dioxide nanoparticles for neuroprotection by reducing oxidative stress and modulating inflammatory microenvironment in acute ischemic stroke[J]. Adv Sci (Weinh), 2021, 8(20): e2101526.
|
[17] |
Ji J, Wang J, Yang J, et al. The intra-nuclear SphK2-S1P axis facilitates M1-to-M2 shift of microglia via suppressing HDAC1-mediated KLF4 deacetylation[J]. Front Immunol, 2019, 10: 1241.
|
[18] |
Fan Z, Xiao K, Lin J, et al. Functionalized DNA enables programming exosomes/vesicles for tumor imaging and therapy[J]. Small, 2019, 15(47): e1903761.
|
[19] |
Liparulo A, Esposito R, Santonocito D, et al. Formulation and characterization of solid lipid nanoparticles loading RF22-c, a potent and selective 5-LO inhibitor, in a monocrotaline-induced model of pulmonary hypertension[J]. Front Pharmacol, 2020, 11: 83.
|
[20] |
Wang Y, Wang Y, Li S, et al. Functionalized nanoparticles with monocyte membranes and rapamycin achieve synergistic chemoimmunotherapy for reperfusion-induced injury in ischemic stroke[J]. J Nanobiotechnology, 2021, 19(1): 331.
|
[21] |
Li Z, Zhang X, Liu C, et al. Macrophage-biomimetic nanoparticles ameliorate ulcerative colitis through reducing inflammatory factors expression[J]. J Innate Immun, 2021: 1-13.
|